Is Pluri Inc. (PLUR) overvalued? · rev $1.3M
Pluri Inc. (PLUR) is a biotechnology company listed on NASDAQ.
This page asks whether Pluri Inc. (PLUR) looks expensive on cached numbers — not a short thesis.
Latest reported PLUR revenue for 2025-06-30 was $1.3M. Net income was -$23.3M. Revenue was up 309.8% from 2024-06-30 to 2025-06-30. PLUR currently screens at market cap $24.3M.
PLUR currently screens at market cap $24.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PLUR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PLUR stock page for the full model, not this heading.
Not investment advice.